Ian Spendlove

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Helicobacter Pylori

Endothelial Cells

Long Non Coding Rna

Top Venues

The Journal of pathology

Cancer research

EMBO molecular medicine

University of Nottingham

University of Nottingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham Aug 1o 2013

United Kingdom

Associate Professor :: Department of Molecular Oncology

Education History

University of Nottingham Sep 1o 1988 - May 1o 1992

United Kingdom

PHD :: Biochemistry

Publications

Kazuyo Kaneko, Abed M Zaitoun, Darren P Letley, Joanne L Rhead, Javier Torres, Ian Spendlove, John C Atherton, Karen Robinson
The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa. The Journal of pathology 258 (2) (2022)
Mireille Vankemmelbeke, Richard S McIntosh, Jia Xin Chua, Thomas Kirk, Ian Daniels, Marilena Patsalidou, Robert Moss, Tina Parsons, David J Scott, Gemma Harris, Judith M Ramage, Ian Spendlove, Lindy G Durrant
Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement. Cancer research 80 (16) (2020)
Daniel E Foxler, Katherine S Bridge, John G Foster, Paul Grevitt, Sean Curry, Kunal M Shah, Kathryn M Davidson, Ai Nagano, Emanuala Gadaleta, Hefin I Rhys, Paul T Kennedy, Miguel A Hermida, Ting-Yu Chang, Peter E Shaw, Louise E Reynolds, Tristan R McKay, Hsei-Wei Wang, Paulo S Ribeiro, Michael J Plevin, Dimitris Lagos, Nicholas R Lemoine, Prabhakar Rajan, Trevor A Graham, Claude Chelala, Kairbaan M Hodivala-Dilke, Ian Spendlove, Tyson V Sharp
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia. EMBO molecular medicine 10 (8) (2019)